Literature DB >> 24614590

Therapy: Antiphospholipid syndrome research needs more collaboration.

Doruk Erkan1, Michael D Lockshin1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24614590     DOI： 10.1038/nrrheum.2014.39

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  9 in total

1.  Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.

Authors:  Michael D Lockshin; Mimi Kim; Carl A Laskin; Marta Guerra; D Ware Branch; Joan Merrill; Michelle Petri; T Flint Porter; Lisa Sammaritano; Mary D Stephenson; Jill Buyon; Jane E Salmon
Journal:  Arthritis Rheum       Date:  2012-07

Review 2.  The pathogenesis of the antiphospholipid syndrome.

Authors:  Bill Giannakopoulos; Steven A Krilis
Journal:  N Engl J Med       Date:  2013-03-14       Impact factor: 91.245

3.  APS ACTION--AntiPhospholipid Syndrome Alliance For Clinical Trials and InternatiOnal Networking.

Authors:  D Erkan; M D Lockshin
Journal:  Lupus       Date:  2012-06       Impact factor: 2.911

4.  Primary antiphospholipid syndrome: functional outcome after 10 years.

Authors:  D Erkan; Y Yazici; R Sobel; M D Lockshin
Journal:  J Rheumatol       Date:  2000-12       Impact factor: 4.666

5.  Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients.

Authors:  R Cervera; R Serrano; G J Pons-Estel; L Ceberio-Hualde; Y Shoenfeld; E de Ramón; V Buonaiuto; S Jacobsen; M M Zeher; T Tarr; A Tincani; M Taglietti; G Theodossiades; E Nomikou; M Galeazzi; F Bellisai; P L Meroni; R H W M Derksen; P G D de Groot; M Baleva; M Mosca; S Bombardieri; F Houssiau; J-C Gris; I Quéré; E Hachulla; C Vasconcelos; A Fernández-Nebro; M Haro; Z Amoura; M Miyara; M Tektonidou; G Espinosa; M L Bertolaccini; M A Khamashta
Journal:  Ann Rheum Dis       Date:  2014-01-24       Impact factor: 19.103

6.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321

7.  Hospital based prospective longitudinal clinical and immunologic study of 179 patients of primary anti-phospholipid syndrome.

Authors:  Nand K Singh; Dibya R Behera; Ankit Agrawal; Mahendra Narayan Singh; Vikash Kumar; Manoj Godhra; Anurag Gupta; Devesh P Yadav; Usha Singh; Lakshmi Kant Pandey; Manjari Matah
Journal:  Int J Rheum Dis       Date:  2013-10       Impact factor: 2.454

Review 8.  Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis.

Authors:  Laurent Arnaud; Alexis Mathian; Amelia Ruffatti; Doruk Erkan; Maria Tektonidou; Ricard Cervera; Ricardo Forastiero; Vittorio Pengo; Marc Lambert; Maria Angeles Martinez-Zamora; Juan Balasch; Stephane Zuily; Denis Wahl; Zahir Amoura
Journal:  Autoimmun Rev       Date:  2013-11-02       Impact factor: 9.754

Review 9.  14th International Congress on Antiphospholipid Antibodies: task force report on antiphospholipid syndrome treatment trends.

Authors:  Doruk Erkan; Cassyanne L Aguiar; Danieli Andrade; Hannah Cohen; Maria J Cuadrado; Adriana Danowski; Roger A Levy; Thomas L Ortel; Anisur Rahman; Jane E Salmon; Maria G Tektonidou; Rohan Willis; Michael D Lockshin
Journal:  Autoimmun Rev       Date:  2014-01-24       Impact factor: 9.754
  9 in total
  2 in total

1.  Soluble analog of ApoER2 targeting beta2-glycoprotein I in immune complexes counteracts hypertension in lupus-prone mice with spontaneous antiphospholipid syndrome.

Authors:  A Kolyada; Q Ke; I Karageorgos; P Mahlawat; D A Barrios; P M Kang; N Beglova
Journal:  J Thromb Haemost       Date:  2016-05-03       Impact factor: 5.824

2.  Increased heterogeneity of brain perfusion is an early marker of central nervous system involvement in antiphospholipid antibody carriers.

Authors:  Ting-Syuan Lin; Pei-Ying Hsu; Chin-Hao Chang; Chi-Lun Ko; Yu-Min Kuo; Yen-Wen Wu; Ruoh-Fang Yen; Cheng-Han Wu; Ko-Jen Li; Yenh-Chen Hsein; Song-Chou Hsieh
Journal:  PLoS One       Date:  2017-08-01       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.